Cognizant Technology Solutions Corporation (CTSH) Q2 2025 Earnings Call Transcript

Access earnings results, analyst expectations, report, slides, earnings call, and transcript.

Overview

The earnings call reflects strong financial performance, with 8.2% revenue growth and improved operating margins. The company shows strategic focus on AI investments and talent development, while maintaining a positive outlook on bookings and innovation. Despite some vague responses, the guidance remains optimistic with increased shareholder returns and strategic capital allocation. The Q&A session supports a positive sentiment, emphasizing growth in deals and market share gains. Overall, the combination of strong financial metrics, optimistic guidance, and strategic initiatives suggest a positive stock price movement.

Key Financial Performance

Revenue Second quarter revenue grew 7.2% year-over-year in constant currency to $5.2 billion. Growth was led by Financial Services and Health Sciences and benefited from the ramp of recently won large deals.

Bookings Q2 bookings grew 18% year-over-year, translating to trailing 12 months growth of 6%. The TCV of large deals more than doubled year-over-year, driven by 6 large deals with TCV of $100 million or greater, including 2 mega deals valued around $1 billion each.

Adjusted Operating Margin Adjusted operating margin of 15.6% improved by 40 basis points year-over-year. This improvement was attributed to disciplined cost management and productivity initiatives.

Headcount Headcount grew about 2% sequentially, led by hiring of recent college graduates. Trailing 12 months voluntary attrition for tech services declined by 60 basis points sequentially to 15.2%.

Free Cash Flow Second quarter free cash flow was $331 million compared to $183 million a year ago, reflecting a significant improvement.

DSO (Days Sales Outstanding) DSO of 83 days increased by 2 days sequentially and by 3 days year-over-year.

Capital Return to Shareholders During the second quarter, $521 million was returned to shareholders through share repurchases and dividends, bringing the first half total to $885 million.

You have reached the limit Upgrade to access full content

Get started

Operating Highlights

AI-led opportunities: Continued strategic focus on AI-led opportunities, delivering wins in AI efficiency-led large deals and innovation-led projects with Agentic AI unlocking new revenue pools.

Agent Foundry: Launched Cognizant Agent Foundry to accelerate enterprise-scale adoption of Agentic AI, powered by Neuro AI suite and a strong AI Partner Ecosystem.

AI Training Data Services: Introduced Cognizant AI Training Data Services for Global 2000 clients to build, fine-tune, validate, and deploy production-grade AI models at scale.

Autonomous Customer Engagement: Introduced Cognizant Autonomous Customer Engagement platform built with Google Cloud, using Agentic AI for smarter customer service.

Large Deals: Secured 6 large deals with TCV of $100 million or greater, including 2 mega deals valued at $1 billion each.

Geographic Growth: Revenue grew across all major regions, with North America leading at 8% growth, followed by Europe at 4% and Rest of the World at 6%.

Industry Growth: Strong growth in Financial Services (6%) and Health Sciences (5%), driven by digital engineering, legacy modernization, and AI-led productivity deals.

Revenue Growth: Achieved 7.2% year-over-year revenue growth in constant currency, reaching $5.2 billion.

Margin Expansion: Adjusted operating margin improved by 40 basis points year-over-year to 15.6%.

Headcount Growth: Headcount grew 2% sequentially, with a focus on hiring recent college graduates.

AI Strategy: Progressed on 3-Vector AI strategy, focusing on productivity, industrializing AI, and agentifying enterprises.

Talent Development: Expanded operations in Visakhapatnam, launched a new learning center in Chennai, and introduced AI training initiatives for employees.

Partnerships: Formed strategic partnerships, including with WRITER for Agentic AI and a major biopharmaceutical company for AI-led IT transformation.

You have reached the limit Upgrade to access full content

Get started

Risk or Challenges

Economic Environment: Clients are prioritizing productivity due to the current economic environment, which may limit discretionary spending and impact revenue growth.

Regulatory Changes: The recent U.S. Budget Bill changes to Medicaid and tariffs in Life Sciences are creating uncertainty and may weigh on near-term discretionary demand from payers and providers.

Demand Visibility: Visibility into demand remains limited, which could impact the company's ability to forecast and plan effectively.

Discretionary Spending Pressure: Trade policy uncertainty and economic conditions are tempering discretionary spending in certain sectors, such as Products and Resources.

Large Deal Ramp-Up Costs: Initial ramp-up costs for large deals are impacting margins, which could affect profitability in the short term.

Attrition and Talent Management: While voluntary attrition has declined, managing talent in a competitive market remains a challenge, especially as the company scales AI capabilities.

Tax Legislation Impact: The repeal of certain U.S. tax provisions will result in a one-time noncash tax expense of approximately $400 million, impacting financials in the short term.

Sector-Specific Challenges: Life Sciences clients face heightened uncertainty due to tariffs, and the Medicaid changes are expected to impact payer and provider demand.

You have reached the limit Upgrade to access full content

Get started

Guidance & Outlook

Revenue Growth: For Q3 2025, revenue is expected to grow 3.5% to 5% year-over-year in constant currency. For full year 2025, revenue is projected to grow 4% to 6% in constant currency, with inorganic contribution of approximately 250 basis points.

Adjusted Operating Margin: Full year 2025 adjusted operating margin is expected to be in the range of 15.5% to 15.7%, representing 20 to 40 basis points of expansion.

Free Cash Flow: Free cash flow is expected to represent approximately 100% of net income for 2025, excluding a one-time noncash tax charge in Q3.

Capital Return: The company plans to return $2 billion to shareholders in 2025, an increase of $300 million from prior guidance, driven by higher share repurchases.

EPS Guidance: Full year 2025 EPS is expected to range from $5.08 to $5.22, representing 7% to 10% year-over-year growth.

Demand Environment: The low end of the revenue guidance assumes further deterioration in the demand environment, while the high end assumes an improved demand environment supported by a strong large deal pipeline.

AI and Strategic Investments: The company is focusing on AI-led automation and pyramid optimization to support gross margin over the medium term. Investments in AI platforms, agentic systems, and talent development are expected to drive future growth.

You have reached the limit Upgrade to access full content

Get started

Shareholder Return Plan

Capital Returned to Shareholders: During the second quarter, we returned $521 million of capital to shareholders through share repurchases and dividends, bringing the first half total to $885 million.

Free Cash Flow: Second quarter free cash flow was $331 million compared to $183 million a year ago.

Future Capital Allocation: Due to cash flow benefit from the U.S. Budget Bill, we now expect free cash flow to represent approximately 100% of net income, excluding the onetime noncash charge that will be recorded in the third quarter.

Share Repurchases: We returned $521 million of capital to shareholders through share repurchases and dividends in Q2, with $1.4 billion planned for repurchases in 2025.

Increased Shareholder Return: For the full year, we plan to return $2 billion to shareholders, an increase of $300 million from last quarter, driven by higher expected share repurchases.

You have reached the limit Upgrade to access full content

Get started

Key Q&A

Q:What is the outlook for bookings in the second half of the year?

A:Management reported a strong bookings mix with 18% year-over-year growth and 6% trailing 12 months. They highlighted a healthy mix of renewals and new business, including 6 large deals and 2 mega deals worth over $1 billion. They are optimistic about maintaining this momentum, driven by both productivity and innovation-led deals.

Q:What is the gross margin outlook for the second half of the year?

A:Management expects stable gross margins year-over-year with slight sequential improvement. They are balancing resource utilization and investments, including a headcount increase of 7,500 employees, to support large deal ramps.

Q:How is Cognizant pricing and incorporating its IP into deals?

A:Cognizant is focusing on interdisciplinary capabilities layered with IP on the edge, which they believe creates differentiation. They are investing in platforms, tools, and reusable agent components to make their offerings sticky and premium. They are optimistic about monetizing innovation capital in a nonlinear way.

Q:What is the update on capital allocation and acquisitions?

A:Cognizant has increased its 2025 capital return target to $2 billion, with $1.4 billion for share repurchases and $600 million for dividends. They have allocated $500 million for M&A this year and have a decent pipeline for the second half.

Q:What is the expected Q4 exit rate and its factors?

A:The Q4 exit rate depends on Q3 and Q4 performance. Management provided a wide range, with the lowest end being negative, the midpoint around 1%, and the upper end just under 4%. They are anchored around the midpoint of their guidance.

Q:Which verticals and geographies are expected to perform well in the second half of the year?

A:Financial Services is expected to perform well, driven by innovation dollars. Health care is seen as an opportunity for applying technology to reduce operational overhead. All geographies, including the U.S., Europe, and Asia Pacific, are performing well, with the U.S. showing strong results.

Q:What is the progress of the 3-Vector approach?

A:Vector 1 (hyper-productivity) is significantly ahead, driven by uncertain markets and client value focus. Vector 2 (industrializing AI) and Vector 3 (agentifying the enterprise) are interlinked, with Vector 3 gaining momentum in areas like customer care and financial services.

Q:How is Cognizant addressing health care headwinds?

A:Cognizant sees health care as an opportunity, focusing on applying technology to reduce operational costs and improve outcomes. They are optimistic about leveraging AI-led transformation to unlock productivity in the sector.

Q:What is Cognizant's approach to the convergence of IT services and BPM?

A:Cognizant views the convergence as an opportunity to apply AI and agentic solutions to operations. They are focusing on creating new labor pools and addressing new spend areas, leveraging their technology progress to disrupt existing portfolios.

Q:What is the outlook for headcount growth and utilization rates?

A:Headcount increased by 7,500 in Q2, primarily due to hiring recent college graduates. Management expects some additional increases in the second half but will focus on AI-led productivity to optimize resources. Utilization rates are expected to remain stable.

Q:What is driving Cognizant's market share gains in bookings?

A:Cognizant attributes its market share gains to competitive pricing, strong execution, and the ability to sole-source and originate deals. They have seen a healthy mix of new business, renewals, and innovation-led deals.

Q:How are clients approaching innovation spend given technological advancements?

A:Clients are increasingly open to innovation-led process changes, focusing on improving experience, reducing cycle times, and increasing throughput. Cognizant is leveraging its interdisciplinary capabilities to address these needs and capture new spend cycles.

Q:How does Cognizant view competition from frontier model companies like OpenAI?

A:Cognizant believes that frontier model companies lack the domain, operations, and system integration expertise needed to implement business process changes. They see their role as building the necessary layers to make AI technology work in enterprise contexts.

Q:Review of Unclear Management Responses

A:Management avoided providing specific details on the Q4 exit rate, instead offering a wide range of possibilities. They also used vague language when discussing the impact of innovation spend and technological advancements, without providing concrete examples or data.

You have reached the limit Upgrade to access full content

Get started

Earnings Word Cloud

The most frequently occurring keywords in this quarter's earning call

CTSH Transcript

Cognizant Technology Solutions Corporation (CTSH) Q3 2025 Earnings Call Transcript

Positive10-29

The earnings call highlights strong AI-led growth, increased shareholder returns, and an optimistic outlook for 2026. Despite slight concerns over gross margin impacts and secondary listing uncertainties, the company’s strategic investments in AI and partnerships, alongside a significant increase in large deal contracts, suggest a positive trajectory. The increased capital return and promising AI-driven initiatives further bolster a positive sentiment, likely leading to a stock price increase.

Cognizant Technology Solutions Corporation (CTSH) Presents At Goldman Sachs Communacopia + Technology Conference (Transcript)

Neutral9-10

Cognizant Technology Solutions Corporation (CTSH) Presents At Citi's 2025 Global Technology, Media And Telecommunications Conference Transcript

Neutral9-3

Cognizant Technology Solutions Corporation (CTSH) Q2 2025 Earnings Call Transcript

Positive7-30

CTSH Slides

Cognizant Q2 2025 slides: Revenue up 8.1%, raises full-year guidance

2025-07-30

CTSH Report

COGNIZANT TECHNOLOGY SOLUTIONS CORP 10-K

10-K

2025-02-12

COGNIZANT TECHNOLOGY SOLUTIONS CORP 10-Q

10-Q

2024-10-31

COGNIZANT TECHNOLOGY SOLUTIONS CORP 10-Q

10-Q

2024-08-01

COGNIZANT TECHNOLOGY SOLUTIONS CORP 10-Q

10-Q

2024-05-02

Frequently Asked Questions

Where does this earnings call transcript come from?

All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.

How soon is the transcript available after the earnings call ends?

Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.

Is the transcript edited or altered in any way?

No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.

Why do some answers appear as “Unclear” or “Inaudible”?

When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.

Who creates the AI Summary and Key Q&A highlights shown above the transcript?

They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.